Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

TitleCardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Publication TypeJournal Article
Year of Publication2019
JournalThe New England journal of medicine
Volume380
Issue1
Pagination11-22
Date Published2019 Jan 3
ISSN0028-4793
AbstractPatients with elevated triglyceride levels are at increased risk for ischemic events. Icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, lowers triglyceride levels, but data are needed to determine its effects on ischemic events.
URLhttp://www.nejm.org/doi/full/10.1056/NEJMoa1812792?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
DOI10.1056/NEJMoa1812792
PubMed Linkhttp://www.ncbi.nlm.nih.gov/pubmed/30415628?dopt=Abstract
Short TitleN Engl J Med